A ntiretroviral therapy (ART) and human immunodeficiency virus research have achieved unprecedented series of breakthroughs that have translated into the largely successful management of what is now considered a chronic treatable infection (18, 33) . In long-term-treated patients, the withdrawal of ART leads to a rebound of the plasma viral load, indicating that current treatment is unable to eradicate the virus from an infected patient despite apparently suppressed viral replication. Multiple factors may affect HIV persistence in the presence of antiretroviral treatment. Persistent viremia may arise from long-lived productively infected cells that were infected prior to therapy initiation or from the intermittent reactivation of latently infected cells. Alternatively, residual viral replication during ART or in sanctuary sites into which antiretrovirals poorly penetrate would explain HIV persistence (12) . The degree to which HIV can effectively replicate during therapy is a highly contentious issue (14) , and it is actively being studied in patients and cell culture models.
Recently, Sigal et al. (36) suggested that cell-to-cell transmission of HIV represents a mechanism contributing to virus escape from the action of antiretrovirals and a mode of HIV persistence during antiretroviral therapy. A mathematical model was used to demonstrate that the drug concentration required to prevent a single transmitted virion from infecting a target cell is much lower than that needed to stop multiple transmitted virus particles from infecting the same cell. Sigal et al. defined a transmission index (T x ) as the ratio between the number of infected cells in the presence of drug (I d ) and the fraction of cells infected in the absence of drug (I), adding further complexity to the model by associating T x with the multiplicity of infection (MOI; abbreviated as "m" in the equation presented below), defined as the product of virus particle number and the infectivity per virus particle. Then, cell-to-cell spread was used as the experimental model to recapitulate the effect of multiple virus transmission.
We and others have demonstrated that coculture of HIV-1-infected cells with CD4 ϩ T cells leads to detection of large amounts of enveloped virions in clathrin-coated endosomes (6, 8, 9, 22, 27, 28, 31 ) that persist for 48 h (6) or as long as the target cells are cultured with infected cells. Cell-to-cell HIV transfer is blocked by agents that prevent virus attachment (7), but is resistant to agents targeting HIV coreceptors, gp41-dependent fusion inhibitors or neutralizing antibodies, and, importantly, agents targeting the reverse transcriptase (RT) (11, 25, 31) . Endocytic transfer of HIV may lead to virus replication, but incoming viral antigen in target cells may incorrectly be interpreted as a marker of virus replication. Therefore, the aim of the present work was to evaluate the efficacy of known antiretrovirals in cell-associated virus transmission compared to cell-free virus infection. We show that anti-HIV drugs are able to block viral DNA production and the inherent virus replication in cell-to-cell viral transmission, recapitulating the efficacy of antiretrovirals in cell-free virus infection.
MATERIALS AND METHODS

Cells.
Peripheral blood mononuclear cells (PBMCs) from healthy donors were purified by Ficoll-Hypaque sedimentation. CD4 ϩ T lymphocytes were immediately purified (Ͼ95%) from PBMCs by negative selection using the CD4 ϩ T cell enrichment kit (Stem Cell Technologies, Vancouver, Canada) and grown in RPMI 1640 -L-glutamine medium (Gibco, Madrid, Spain). Chronically HIV-1-infected MOLT cells were generated after infection of the MOLT-4/CCR5 lymphoid cell line (AIDS Research and Reference Reagent Program, National Institutes of Health, Bethesda, MD) with an NL4-3 X4 HIV-1 strain (HIV-1 NL4-3 ) constructed in an HIV HXB2 backbone (29) . After the infection peak, the persistently infected culture was grown and characterized for Env expression and virus production (5). Uninfected MOLT-4/CCR5 cells were used as negative controls in all experiments. MOLT-4, the lymphoid T cell line MT-4 (obtained from the Medical Research Council, Centre for AIDS Reagents, London, United Kingdom), and the green fluorescent protein (GFP) expressing CEM-GFP cell line (AIDS Research and Reference Reagent Program, National Institutes of Health, Bethesda, MD) were cultured in RPMI (Gibco, Madrid, Spain). Media were supplemented with 10% heatinactivated fetal calf serum (FCS; Life Technologies, Madrid, Spain), 100 U/ml penicillin, and 100 g/ml streptomycin.
Cocultures of infected and uninfected cells. Primary CD4 ϩ T cells were cocultured with uninfected or HIV-1 persistently infected MOLT cells as previously described (6, 7, 11) . Briefly, target cells (purified primary CD4
ϩ T cells or MT-4 cells) were first labeled with the cell tracer DDAO-SE (Molecular Proves, Life Technologies) at a final concentration of 0.5 g/ml for 30 min. Cells were extensively washed before being mixed with effector MOLT cells. Both effector and target cells (2 ϫ 10 5 cells each in a 1:1 ratio) were cocultured in a 96-well culture plate in a final volume of 0.2 ml in the absence or the presence of the following HIV-1 inhibitors: the reverse transcriptase inhibitors (RTIs) zidovudine (AZT; 4 M) (Sigma-Aldrich) and tenofovir disoproxil fumarate (TDF; 4 M) (AIDS Research and Reference Reagent Program) and 10 g/ml of the neutralizing anti-gp120 monoclonal antibody (MAb) IgGb12 (Polymun Scientific). After overnight coculture, primary CD4 ϩ T cells were purified (Ͼ99% purity) from MOLT cells by fluorescence-activated cell sorting (FACS) (FACSAria II; BD Biosciences). Recovered CD4 ϩ T cells were maintained in the presence of the same compound used during the initial coculture. 4 MOLT cells at a 9:1 ratio. For both ratios, cocultures with MOLT uninfected cells were performed as negative controls. Cell-free and cellassociated infections were carried out for 48 h in the presence or absence of various concentrations of AZT and TDF. Forty-eight hours postinfection, cells were recovered and infection was quantified by emission of green fluorescent protein (GFP) signal in target cells using flow cytometry in coculture infections. DDAO-SE and GFP double-positive cells, considered donor-target cell fusions, were excluded from the analysis. To quantify total GFP expression, cells were also viewed in a Nikon eclipse TE-200 microscope coupled to a charge-coupled device (CCD) Kappa camera, and the images obtained were used to quantify GFP expression. Quantification of total GFP was performed by evaluating and quantifying the average intensity of GFP signal for every image as implemented in the Launch VisionWorks software.
HIV-independent transactivation of HIV LTR in CEM-GFP cells. Cocultures between HeLa Env
ϩ cells (National Institute for Biological Standards and Control [NIBSC], United Kingdom) and CEM-GFP cells were performed to demonstrate unspecific replication-independent long terminal repeat (LTR)-driven expression of GFP in CEM-GFP cells (10, 19) . A total of 2 ϫ 10 5 HeLa Env ϩ cells (also expressing Tat and Rev proteins) were seeded in a 24-well plate the day before the initiation of the coculture. After the removal of the supernatant, the coculture was initiated by the addition of 2 ϫ 10 5 CEM-GFP cells in the presence or the absence of 4 M tenofovir (TFV) in a final volume of 1 ml. Cocultures with the HeLa cell line TZM-bl (Env Ϫ ) were used as negative controls. Twenty-four hours later, cells were recovered and visualized in a Nikon eclipse TE-200 microscope coupled to a CCD Kappa camera.
Quantitative real-time PCR for proviral HIV-1 DNA detection. Proviral DNA was quantified as described before (3, 4) . Briefly, cells were pelleted, supernatant was removed, and pellets were frozen at Ϫ20°C until use. Total cellular DNA was extracted using the QiaAmp DNA-extraction kit (QIAmp DNA blood minikit; Qiagen, Madrid, Spain) as recommended by the manufacturer. Quantitative amplification of LTR was performed using the following primers and probe (forward primer, 5=-GAC GCAGGACTCGGCTTG-3=; reverse primer, 5=-ACTGACGCTCTCGCA CCC-3=; probe, 5=-TTTGGCGTACTCACCAGTCGCCG-3=, labeled with the fluorophore 6-carboxyfluorescein [FAM] and the quencher 6-carboxytetramethylrhodamine [TAMRA]). To normalize HIV copy values per cell, amplification of the cellular RNase P gene was performed using the TaqMan RNase P control reagents kit (Applied Biosystems, Roche, Barcelona, Spain). For each experiment, DNA extracted from 8E5/LAV cells (harboring one copy of integrated HIV-1 per cell) was used to build a standard curve of the proviral DNA copy number, and DNA extracted from uninfected CEM-GFP cells was used to build a standard curve of the cell number. The PCR was performed in a total volume of 50 l using 1ϫ TaqMan Universal PCR master mix (Applied Biosystems), a 0.9 M concentration of the primers, 0.25 M probe, and 5 l of the DNA sample. Reactions were analyzed with the ABI Prism 7000 instrument using SDS 1.1 software (Applied Biosystems). For each experiment with cell-associated infections, the background of proviral DNA copy number coming from MOLT infected cells was subtracted using a control condition in which an equal cell number of MOLT NL4-3 cells were cultured alone.
Calculation of T x . The transmission index (Tx), designed to quantify the infection sensitivity to drugs (36) , was calculated as the fraction of cells infected in the presence of drug (I d ) divided by the fraction of cells infected in the absence of drug (I). T x depends on the multiplicity of infection (MOI) (symbolized here by the variable m), defined as a fraction of the number of infected cells by the number of target cells, and on the reduction of infection, f(d), in a given drug concentration (d) as in the equation
In the present study, m corresponds to the percentage of infected cells (GFP ϩ or p24 ϩ ) in the untreated condition, which was set to roughly 4% of GFP ϩ cells under both cell-free and cell-associated infections. For each drug concentration tested, the T x was calculated as the fraction of GFP ϩ cells in the presence of drug by the percentage of GFP ϩ cells in the absence of drug. T x was equally calculated using the total HIV DNA or using the data obtained with the intracellular p24 antigen staining.
RESULTS
Cell-to-cell transmission of HIV-1 in the absence of virus replication. We have previously shown that HIV-1 persistently infected or acutely infected T cells or dendritic cells may transfer HIV-1 particles to intracellular compartments in target CD4
ϩ T cells (6, 7, 11) . After overnight cocultures of HIV-1 NL4-3 -infected MOLT cells with nonstimulated primary CD4 ϩ T lymphocytes, roughly 20% of target cells were HIV antigen positive compared to the untreated condition (Fig. 1a, black bars) . Antigen detection was resistant to the RT inhibitors AZT (4 M) and TDF (4 M), but was inhibited by the attachment inhibitor IgGb12 (10 g/ml). However, at the same time point, cells remained negative of viral DNA, as measured by quantitative PCR (qPCR) (Fig. 1b, black  bars) , indicating that antigen detected in CD4 ϩ T cells was not the product of virus replication in the target cells, but was transmitted from the infected MOLT cells. When HIV antigen-positive target cells were sorted and left for 5 days in the presence of the inhibitors, only the untreated cells remained positive for p24 antigen staining (Fig. 1a, white bars) . Proviral DNA detection (Fig. 1b , white bars) and p24 antigen production in the supernatant (Fig.  1c) were only detected in untreated cells, indicating that the antiretrovirals used effectively block virus replication after cell-to-cell transmission.
In lymphoid MT-4 cells, captured virus could be detected as early as 2 h post-coculture, reached a maximum at 24 h, and was maintained for up to 48 h (Fig. 2a) . Early flow cytometry detection of intracellular virus antigen may indicate that HIV antigen in short-term cocultures does not accurately measure HIV infectivity. To confirm this hypothesis, total viral DNA in target cells was measured by qPCR. Figure 2b shows that despite massive intracellular p24-antigen detection, TDF and AZT clearly blocked infection even after 48 h post-coculture. Cell-free and cell-associated HIV infections were equally sensitive to inhibition by reverse transcriptase inhibitors. To compare drug efficacies in cell-free and cell-associated virus transmission, CEM-GFP cells were cocultured with HIV-1 NL4-3 -infected MOLT cells labeled with DDAO cell tracer or infected with cell-free virus (HIV-1 NL4-3 ), in the presence of various concentrations of the RT inhibitors AZT and TDF. Forty-eight hours postcoculture, infection of target cells was determined by the percentage of cells positive for GFP signal and by proviral DNA detection ( Fig. 3 and 4) . As indicated in reference 36, care was taken to normalize virus input in both cell-free and cell-associated cultures, leading to roughly identical results in the percentage of GFP ϩ cells in the untreated condition at 48 h (Fig. 3a) . A significantly high virus concentration, roughly 5 g/ml of p24 antigen and Ͼ25-fold higher of the commonly used virus input in drug susceptibility studies in MT-4 cells (20, 21) , was required to achieve 4 to 5% GFP ϩ cells in cell-free infections. Under these conditions, both AZT and TDF effectively blocked virus replication with similar 50% effective concentrations (EC 50 s) measured either by GFP signal or total viral DNA in target cells (Table 1) .
Flow cytometry evaluation of LTR-dependent GFP expression in cell-associated infections underestimates virus replication and may not accurately evaluate antiviral efficacy. Cell-tocell culture of infected and uninfected cells may lead to Tatdependent transactivation of the HIV LTR in the absence of virus replication (10, 19, 38) . Cocultures of HeLa Env ϩ cells, expressing Tat and Rev proteins, with CEM-GFP cells were performed to show HIV-1 replication-independent LTR-driven expression of GFP. Transactivation of HIV-1 LTR occurred in the absence of virus replication and could not be inhibited by TDF (see Fig. S1 in the supplemental material).
When comparing cell-free and cell-associated infections under conditions in which GFP expression was normalized to that of target cells by flow cytometry, the average fluorescence intensity (mean fluorescent intensity [MFI]) of the complete culture measured by fluorescence microscopy was higher in cell-associated virus than that in cell-free infections (Fig. 3b) . AZT and TDF blocked total GFP expression measured by microscopy in cell-free infections, but inhibition was only partial in cell-associated infections (48% and 25% for AZT and TDF, respectively), indicating that GFP at 48 h was a reflection of both Tat-dependent transactivation and a minor component of effective viral replication. Conversely, flow cytometry data suggest a very similar inhibition in cell-free and cell-associated infections (75% versus 60% for AZT and 95% versus 84% for TDF, comparing cell-free versus cell-associated infections). This is due to the incapacity of flow cytometry to quantify GFP ϩ giant cell fusions, which on the other hand, may have an important component of Tat-dependent transactivation due to Env-mediated cell fusion.
To further confirm the effect of antiretrovirals in cell-to-cell infections, total viral DNA was measured under conditions in which GFP expression was normalized to that of target cells by flow cytometry (Fig. 4a and c) . Total viral DNA was significantly higher in cell-associated infection; however, both AZT and TDF potently blocked total viral DNA with similar potencies ( Fig. 4b  and d ; Table 1 ). These results could be interpreted as cell-to-cell transmission being a more efficient mechanism of infection. However, when infectivity was normalized to total DNA by reducing the number of infected cells in cocultures, the effects of both AZT and TDF also showed similar potencies (Fig. 4e to h ), indicating that total viral DNA is a reflection of the higher multiplicity of infection in cocultures that is not adequately quantified by gating GFP ϩ single cells, as indicated by Sigal et al. (36) . The lack of total inhibition of GFP ϩ cells by AZT in cell-free virus infections may be a reflection of the high virus input that was required to achieve an effect comparable to that observed in cell-associated infection experiments.
The transmission index differs depending on how HIV infection is measured. The transmission index (T x ) represents the ratio between the fraction of infected cells in the presence of drug (I d ) divided by the fraction of cells infected in the absence of drug (I), and it is dependent on the MOI (m), defined as the product of the virus particle number and the infectivity per virus particle (36) . The calculated T x s considering the intracellular p24 antigen staining measurements (i.e., transfer of virus) or the effective HIV infection (i.e., total viral DNA quantification) are completely different ( Fig. 5a and b) . No inhibition of intracellular virus antigen was noted even in the presence of TDF (4 M), but complete inhibition of replication 48 h post-coculture was observed (Fig. 3 to 5 ). According to GFP expression, the potency of TDF or AZT in cellfree virus infection could not be recapitulated in cell-to-cell transmission but was clearly accomplished when total viral DNA was measured ( Fig. 5c and d) . Thus, AZT and TDF blocked virus replication in cells that were apparently infected, as measured by FACS analysis.
DISCUSSION
Cell-to-cell HIV transmission has often been associated with a more efficient mechanism of infection (16, 17, 32, 34, 37) . Infected cells bind and interact with target CD4 ϩ T cells in manners that promote virus transmission through the so-called "virological synapse" in which the interaction between CD4 and the HIV envelope glycoprotein plays a prominent role (22, 31, 35) . Effective transmission of virus is a CD4-dependent process leading to virus internalization and uncoating, reverse transcription, and subsequent steps leading to virus production from the infected cell. ϩ T lymphocytes was performed for 48 h in the presence or absence of TDF (4 M) and IgGb12 (10 g/ml). Data obtained by intracellular p24 antigen staining (black bars) and proviral DNA quantification (white bars) were used to calculate the T x (36) . The T x was also calculated using GFP data and proviral DNA quantification after cell-free (black bars) and cell-associated (white bars) infections performed for 48 h using CEM-GFP target cells in the presence (ϩ) or absence (Ϫ) of 4 M TDF (TFV) (c) or 4 M AZT (d). The means Ϯ SD from three independent experiments are shown. Cell-to-cell transmission was recently shown as a mechanism to evade inhibition only by the anti-gp120 neutralizing antibodies, including CD4-IgG2 (Pro542), but not when other entry inhibitors were used, such as gp41-directed or cell-directed antibodies (1) . To this end, virus strains requiring addition of DEAE-dextran for cell-free but not for cell-to-cell infection were used in nonlymphoid (HeLa TZM-bl) cells. DEAE-dextran is a nonspecific polycation commonly used to enhance the association of viruses, including HIV, with target cells via relatively nonspecific charge interactions (2, 23) and may severely affect gp120 interactions with the cell surface such as to interfere with the inhibitory effect of gp120-targeting neutralizing antibodies. The results in reference 1 are in contrast to previous observations that virus attachment inhibitors, including CD4-IgG2 (7) and others (24) effectively block cell-to-cell transmission with equal potency to cell-free transmission.
We and others have shown that cell-to-cell contact may lead to the transfer of HIV particles through an endocytic internalization of fully coated virions, readily detectable in CD4 ϩ target cells (8, 22) . However, endocytosis as a means to productive infection is a matter of ample debate. Early and recent evidence indicates that HIV may fuse with endosomal membranes to initiate a productive infection (13, 15, 28, 30) , questioning the general understanding that virus entry occurs at the cell surface. Here, we recapitulate these results to demonstrate that evaluation of the presence of virus antigen in target cells at early time points does not accurately measure infectivity or drug efficacy. Conversely, detection of total viral DNA (proviral DNA) as measured by qPCR clearly demonstrates that cells remained infection negative in the presence of antiretroviral agents. Our results contrast with those of Sigal et al. (36) , who evaluated intracellular antigen in cocultures of infected and uninfected cells and assumed that the presence of intracellular HIV antigen in short-term cocultures accurately measured HIV infectivity. Furthermore, to compare cell-free and cell-associated viral transmission, we used a method based on measurement of LTR-driven expression of a given marker to evaluate virus replication in cell-free virus infections, similar to that used by Sigal et al. (36) . A similar multiplicity of infection (m), defined as the number of GFP-positive target cells in the absence of drug, was used to compare drug efficacies in both infection systems. In line with previous observations showing that both cell-to-cell spread and cell-free viral spread were equally sensitive to entry inhibition (7, 24) , drug response curves demonstrated equal efficacy of antiretrovirals, strongly indicating that cell-to-cell transmission may not allow for ongoing virus replication in the presence of antiretroviral therapy.
Similarly to Sigal et al. we have found that antiretroviral drugs differentially blocked GFP expression, which may lead to the assumption that antiretroviral agents effectively block cell-free virus but fail to completely inhibit HIV-1 cell-to-cell spread. However, we show complete inhibition of proviral DNA in the same target cells, which, in contrast with the first assumption, points to a similar efficiency of antiretrovirals in both modes of transmission.
As previously shown (10, 19) , and unlike cell-free virus infection, AZT or TDF cannot block cell-to-cell-mediated Tat-dependent transactivation in the absence of replication. Evaluation of cell cultures by fluorescence microscopy demonstrated that this effect could have important consequences in cell-associated infection when syncytium formation is not impaired by the antiretroviral agent tested. Moreover, the flow cytometry analysis does not entirely evaluate infection as giant syncytia cannot be analyzed. Under these conditions, the potency of antiretroviral agents is being underestimated. Thus, GFP expression may not accurately evaluate drug efficacy in cell-associated virus transmission.
The value of m is similar to the well-known definition of multiplicity of infection (MOI), that is, the ratio of infectious agents per target cell, a concept commonly used to normalize virus titers prior to the evaluation of drug efficacy or virus drug resistance in cell culture experiments. The convention, when comparing the efficacy of a drug against two independent virus strains (or two mechanisms of virus transfer), is to normalize the virus input and then determine the efficacy of the drug, which is commonly reported as the fold change (FC) in EC 50 s. Assuming a similar MOI, the probability to propagate two infectious viruses (or two mechanisms of infection of the same virus) is the same, i.e., the infectivity of a virus particle does not increase by increasing the number of particles (with a higher MOI). A higher MOI raises the number of infectious events. Screening of anti-HIV agents is commonly tested at a low MOI, and plasma viral load is a predictor of treatment efficacy (26) . Sigal et al. conclude that infectivity through cell-to-cell transfer is resistant to the drug, but they have failed to evaluate both conditions (cell-free versus cell-associated infection) at similar MOI, by incorrectly assuming that each virus transferred in coculture will lead to a productive infection.
We concur with the hypothesis that multiple factors affect HIV persistence in the presence of antiretroviral treatment. However, assuming that cell-to-cell spread is permitting ongoing replication despite antiretroviral therapy is difficult to ascertain; although cell-to-cell spread has been well documented in vitro, its relevance in patients is still to be defined. How virus reservoirs are maintained in the presence of therapy has important clinical implications and might be the main barrier to complete clearance of HIV (33) . Therefore, data on cell-to-cell spread should be taken with caution as it is crucial to correctly distinguish and measure abortive virus transfer or surrogate markers of infection (LTR-driven GFP) from effective viral replication.
